Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB Patients

Clinical trial NCT04864366 · UNKNOWN

Trial details

NCT number: NCT04864366
Sponsor: Huashan Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Chronic Hepatitis B

Start date: 2021-04-30
Primary completion: 2023-10-27
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.